{"SPADE_N_06365": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06365", "Peptide Name": "B1-Phe", "Source": "Cathelicidin-BF15 C-terminal amidated derivative B1", "Family": "", "Gene": "Not found", "Sequence": "VKRFKKFFRKLKKFV", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MCF-7 (IC50=1.3 µM); K562 (IC50=3.7 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "GES-1:IC50=107.2 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C100H163N27O16", "Mass": 1999.54, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -0.6, "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities", "Pubmed ID": "25462264", "Reference": "Eur J Med Chem. 2015 Jan 7;89540-8.", "Author": "Deng X, Qiu Q, Yang B, Wang X, Huang W, Qian H.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25462264"}], "Frequent Amino Acids": "KFR", "Absent Amino Acids": "ACDEGHIMNOPQSTUWY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 10, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26340", "Similarity": 1.0, "Sequence": "VKRFKKFFRKLKKFV"}, {"SPADE_ID": "SPADE_UN_22042", "Similarity": 1.0, "Sequence": "KRFKK"}, {"SPADE_ID": "SPADE_N_13148", "Similarity": 1.0, "Sequence": "KKF"}]}}}